Edition:
India

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

106.80USD
17 Aug 2018
Change (% chg)

$-0.04 (-0.04%)
Prev Close
$106.84
Open
$107.04
Day's High
$107.24
Day's Low
$106.41
Volume
150,758
Avg. Vol
192,628
52-wk High
$109.96
52-wk Low
$72.53

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $10,992.71
Shares Outstanding(Mil.): 142.30
Dividend: 0.35
Yield (%): 1.81

Financials

BRIEF-Infoscan Signs LoI With ResMed Polska

* REPORTED ON WEDNESDAY IT HAS SIGNED LETTER OF INTENT (LOI) WITH RESMED POLSKA ON COOPERATION

09 Aug 2018

BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76

* RESMED INC ANNOUNCES RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2018

27 Apr 2018

BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date

* RESMED SAYS ON APRIL 17, 2018 ('CLOSING DATE'), CO ENTERED CERTAIN AMENDED AND RESTATED CREDIT AGREEMENT, DATED AS OF CLOSING DATE - SEC FILING

20 Apr 2018

BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer

* RESMED HIRES BOBBY GHOSHAL AS FIRST CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:

02 Apr 2018

Earnings vs. Estimates